Sickle cell disease in India: Not just a mild condition

被引：0
|
作者：
Kochhar, Manpreet [1 ,2 ]
McGann, Patrick T. [1 ,2 ]
机构：
[1] Brown Univ, Dept Pediat, Div Pediat Hematol Oncol, Warren Alpert Med Sch, Providence, RI 02912 USA
[2] Brown Univ, Hlth Sickle Cell Ctr, Providence, RI USA
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2025年 / 206卷 / 01期
关键词：
sickle cell; sickle cell disease; vaso-occlusive; LOW-DOSE HYDROXYUREA; FETAL-HEMOGLOBIN; ANEMIA;
D O I：
10.1111/bjh.19877
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Sickle cell disease (SCD) is a common and life-threatening global health problem, with more than 500 000 affected infants born annually. The burden of SCD in sub-Saharan Africa is well established, but the comparably high prevalence in India is not well recognized and many consider SCD in India to be less severe. In their paper, a national study in India demonstrated the significant impact of SCD for patients, families and the healthcare system, supporting a call to action to recognize and address SCD as a serious and common health condition in India. Commentary on: Seth et al. Burden of vaso-occlusive crisis, its management, and impact on quality of life of Indian sickle cell disease patients. Br J Haematol 2024 (Online ahead of print). doi: 10.1111/bjh.19829.
引用
收藏
页码：380 / 381
页数：2
相关论文
共 50 条
  • [1] Clinical manifestations of sickle cell disease in India: misconceptions and reality
    Jain, Dipty
    Mohanty, Dipika
    CURRENT OPINION IN HEMATOLOGY, 2018, 25 (03) : 171 - 176
  • [2] A systematic review on hydroxyurea therapy for sickle cell disease in India
    Pandey, Apoorva
    Kaur, Harpreet
    Borah, Sapan
    Khargekar, Naveen
    Karra, Vijay Kumar
    Adhikari, Tulsi
    Jain, Dipty
    Madkaikar, Manisha
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2022, 156 (02) : 299 - 311
  • [3] Sickle cell disease in tribal populations in India
    Colah, Roshan B.
    Mukherjee, Malay B.
    Martin, Snehal
    Ghosh, Kanjaksha
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2015, 141 : 509 - 515
  • [4] Sickle cell disease in India
    Colah, Roshan
    Mukherjee, Malay
    Ghosh, Kanjaksha
    CURRENT OPINION IN HEMATOLOGY, 2014, 21 (03) : 215 - 223
  • [5] Sickle cell disease in India: the journey and hope for the future
    Gupta, Kalpna
    Krishnamurti, Lakshmanan
    Jain, Dipty
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2024, (01) : 1 - 9
  • [6] Sickle cell disease in India: A perspective
    Serjeant, Graham R.
    Ghosh, Kanjaksha
    Patel, Jyotish
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2016, 143 : 21 - 24
  • [7] Evaluation of pharmacological efficacy and safety of hydroxyurea in sickle cell disease: Study of a pediatric cohort from Chhattisgarh, India
    Lad, Harsha
    Naskar, Shoma
    Pasupuleti, S. K. D. B. Punyasri
    Nahrel, Rakesh
    Sihare, Pradeep
    Chandak, Giriraj R.
    Patra, Pradeep K.
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2023, 40 (04) : 395 - 406
  • [8] Sickle Cell Disease in Central India: A Potentially Severe Syndrome
    Jain, Dipty
    Warthe, Vinit
    Dayama, Paridhi
    Sarate, Dilip
    Colah, Roshan
    Mehta, Pallavi
    Serjeant, Graham
    INDIAN JOURNAL OF PEDIATRICS, 2016, 83 (10) : 1071 - 1076
  • [9] Hydroxyurea in Sickle Cell Disease: Our Experience in Western India
    Deshpande, S. V.
    Bhatwadekar, S. S.
    Desai, Parth
    Bhavsar, Tarang
    Patel, Ankit
    Koranne, Amey
    Mehta, Arpan
    Khadse, Shweta
    INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2016, 32 (02) : 215 - 220
  • [10] Sickle cell in sickle cell disease in Latin America and the United States
    Huttle, Alexandra
    Maestre, Gladys E.
    Lantigua, Rafael
    Green, Nancy S.
    PEDIATRIC BLOOD & CANCER, 2015, 62 (07) : 1131 - 1136
12345